Abstract:Objective To analyze the postoperative survival status of liver transplant recipients with end-stage liver disease and to explore the risk factors of long-term survival in liver transplant recipients especially with end-stage liver malignancy. Methods Clinical data of 99 adult patients underwent allogenic liver transplantation with complete follow-up records in Ruijin Hospital, Medical School of Shanghai Jiaotong University from October 2005 to October 2009 were analyzed retrospectively. This study was approved by local ethical committee and the informed consent of all participating subjects was obtained. According to the primary diseases, the patients were divided into the benign group(n=54) and malignancy group (n=45). The 1-, 2-, 3-, 4-year survival rate of recipients were calculated by Kaplan-Meier method and survival curve was drawn and analyzed by Log-rank method. The 12 perioperative variables and 10 variables of liver transplant recipients in the malignancy group were compared by Cox risk regression model to select the risk factors to the recipients' survival. Results Sixty-four cases survived and 35 cases died by October 2009. The 1-, 2-, 3-, 4-year survival rate of recipients were 68%,57%,53% and 53%. The 1-, 2-, 3-, 4-year survival rate in the benign group were 78%, 70%,61% and 61%, while in the malignancy group were 60%, 46%, 46% and 46%. There was no significant difference in the 1-, 2-, 3-, 4-year survival rate between two groups (all in P>0.05). The survival time in the benign group was (35.8±3.0) months while in the malignancy group was (28.7±2.9) months. There was no significant difference between two groups(P>0.05). Cox risk regression analysis showed that the acute physiology and chronic health evaluation (APACHE)Ⅱ scores (odds ratio: 1.21,95% confidence interval:1.05-1.39, P<0.01)of the 12 perioperative variables and the time of anhepatic phase (odds ratio: 2.28,95% confidence interval: 1.26- 4.13, P<0.01) were associated with the postoperative survival time of recipients. The alpha fetal protein (AFP)(odds ratio: 5.94,95% confidence interval: 2.49-14.16,P=0.001) and the tumor microsatellite (odds ratio: 3.40,95% confidence interval: 1.50-7.74, P<0.01) were associated with the postoperative survival time of recipients. Conclusions Preoperative APACHEⅡ scores and the time of intraoperative anhepatic phase are the main risk factors to recipients' survival. Preoperative AFP and tumor microsatellite are the main risk factors that influence the survival time of liver transplant recipients with end-stage liver malignancy.

A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis.

A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

A Simple Prognostic Nomogram of Preoperative Indicator for Patients with Hepatectomy: A MIMIC-based Study

Prediction of Survival after Liver Transplantation for Chronic Severe Hepatitis B Based on Preoperative Prognostic Scores: A Single Center'S Experience in China

Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic models

A Modified Prognostic Score for Critically Ill Patients with Cirrhosis: an Observational Study.

A Score Model for Predicting Post-Liver Trans- Plantation Survival in HBV Cirrhosis-Related Hepatocellular Carcinoma Recipients： a Single Center 5-Year Experience

Pretransplant Prediction of Posttransplant Survival for Liver Recipients with Benign End-Stage Liver Diseases: A Nonlinear Model

Survival status and risk factors of post-transplantation patients with end-stage liver disease

Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients

A prognostic score for patients with acute-on-chronic liver failure treated with plasma exchange-centered artificial liver support system

PROGNOSTIC FACTORS FOR LONG-TERM SURVIVAL IN PATIENTS AFTER LIVER TRANSPLANTATION: A NEW SCORING SYSTEM BASED ON MELD SCORE, MODIFIED WITH SERUM SODIUM

A Combination of Models for End-Stage Liver Disease and Cirrhosis-Related Complications to Predict the Prognosis of Liver Cirrhosis

Prognostic nutritional index as a prognostic factor for very early-stage hepatocellular carcinoma

A nomogram incorporating Psoas muscle index for predicting tumor recurrence after liver transplantation: A retrospective study in an Eastern Asian population

A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma

Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis.

A Simple Four-Factor Preoperative Recipient Scoring Model for Prediction of 90-Day Mortality after Adult Liver Transplantation:A Retrospective Cohort Study.

Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry